CHINA PHARMA HOLDINGS, INC. Increase (Decrease) in Prepaid Expense
CHINA PHARMA HOLDINGS, INC. (CPHI) reported Increase (Decrease) in Prepaid Expense of $44.94 thousand for the 6-month period ending 2023-06-30, per its 10-Q filed 2023-08-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInPrepaidExpense · last filed 2023-08-14
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2023-06-30 was $20.82K, a 19.49% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2023-03-31 was $24.11K, a 156.12% increase year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-12-31 was -$12.32K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for the quarter ending 2022-09-30 was $1.76K, a 90.73% decline year-over-year.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2022 was $24.72K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2021 was -$21.50K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2020 was -$8.31K.
- CHINA PHARMA HOLDINGS, INC. increase (decrease) in prepaid expense for fiscal 2019 was -$45.38K.
| Period end | Increase (Decrease) in Prepaid Expense 3 month | Increase (Decrease) in Prepaid Expense 3 month as first filed | Increase (Decrease) in Prepaid Expense 6 month | Increase (Decrease) in Prepaid Expense 6 month as first filed | Increase (Decrease) in Prepaid Expense 9 month | Increase (Decrease) in Prepaid Expense 9 month as first filed | Increase (Decrease) in Prepaid Expense 12 month | Increase (Decrease) in Prepaid Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2023-06-30 | $20.82K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $44.94K 10-Q · filed 2023-08-14 | $32.61K derived: sum of 3 quarters · filed 2023-08-14 | $34.38K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2023-03-31 | $24.11K 10-Q · filed 2023-05-12 | $11.79K derived: sum of 2 quarters · filed 2023-05-12 | $13.55K derived: sum of 3 quarters · filed 2023-05-12 | $39.42K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-12-31 | -$12.32K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$10.56K derived: sum of 2 quarters · filed 2023-03-30 | $15.31K derived: sum of 3 quarters · filed 2023-08-14 | $24.72K 10-K · filed 2023-03-30 | ||||
| 2022-09-30 | $1.76K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $27.63K derived: sum of 2 quarters · filed 2023-08-14 | $37.05K 10-Q · filed 2022-11-14 | $21.94K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-06-30 | $25.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-14 | $35.28K 10-Q · filed 2023-08-14 | $20.18K derived: sum of 3 quarters · filed 2023-08-14 | $39.20K derived: sum of 4 quarters · filed 2023-08-14 | ||||
| 2022-03-31 | $9.41K 10-Q · filed 2023-05-12 | -$5.69K derived: sum of 2 quarters · filed 2023-05-12 | $13.33K derived: sum of 3 quarters · filed 2023-05-12 | -$2.22K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | -$15.11K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $3.92K derived: sum of 2 quarters · filed 2023-03-30 | -$11.64K derived: sum of 3 quarters · filed 2023-03-30 | -$21.50K 10-K · filed 2023-03-30 | ||||
| 2021-09-30 | $19.02K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $3.47K derived: sum of 2 quarters · filed 2022-11-14 | -$6.40K 10-Q · filed 2022-11-14 | -$329.07K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$15.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | -$25.42K 10-Q · filed 2022-08-11 | -$348.09K derived: sum of 3 quarters · filed 2022-08-11 | -$357.29K derived: sum of 4 quarters · filed 2022-08-11 | ||||
| 2021-03-31 | -$9.87K 10-Q · filed 2022-05-12 | -$332.54K derived: sum of 2 quarters · filed 2022-05-12 | -$341.73K derived: sum of 3 quarters · filed 2022-05-12 | -$198.26K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | -$322.67K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | -$331.86K derived: sum of 2 quarters · filed 2022-03-30 | -$188.39K derived: sum of 3 quarters · filed 2022-03-30 | -$8.31K 10-K · filed 2022-03-30 | ||||
| 2020-09-30 | -$9.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $134.28K derived: sum of 2 quarters · filed 2021-11-12 | $314.36K 10-Q · filed 2021-11-12 | $259.77K derived: sum of 4 quarters · filed 2021-11-12 | ||||
| 2020-06-30 | $143.47K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $323.55K 10-Q · filed 2021-08-13 | $268.97K derived: sum of 3 quarters · filed 2021-08-13 | $246.87K derived: sum of 4 quarters · filed 2021-08-13 | ||||
| 2020-03-31 | $180.08K 10-Q · filed 2021-05-14 | $125.50K derived: sum of 2 quarters · filed 2021-05-14 | $103.40K derived: sum of 3 quarters · filed 2021-05-14 | $142.77K derived: sum of 4 quarters · filed 2021-05-14 | ||||
| 2019-12-31 | -$54.59K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | -$76.68K derived: sum of 2 quarters · filed 2021-03-26 | -$37.31K derived: sum of 3 quarters · filed 2021-03-26 | -$45.38K 10-K · filed 2021-03-26 | ||||
| 2019-09-30 | -$22.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $17.28K derived: sum of 2 quarters · filed 2020-11-13 | $9.21K 10-Q · filed 2020-11-13 | -$30.64K derived: sum of 4 quarters · filed 2020-11-13 | ||||
| 2019-06-30 | $39.37K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-13 | $31.31K 10-Q · filed 2020-08-13 | -$8.55K derived: sum of 3 quarters · filed 2020-08-13 | -$62.73K derived: sum of 4 quarters · filed 2020-08-13 | ||||
| 2019-03-31 | -$8.06K 10-Q · filed 2020-05-14 | -$47.92K derived: sum of 2 quarters · filed 2020-05-14 | -$102.10K derived: sum of 3 quarters · filed 2020-05-14 | -$59.04K derived: sum of 4 quarters · filed 2020-05-14 | ||||
| 2018-12-31 | -$39.85K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | -$94.04K derived: sum of 2 quarters · filed 2020-03-30 | -$50.97K derived: sum of 3 quarters · filed 2020-03-30 | -$53.86K 10-K · filed 2020-03-30 | ||||
| 2018-09-30 | -$54.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | -$11.12K derived: sum of 2 quarters · filed 2019-11-14 | -$14.01K 10-Q · filed 2019-11-14 | $549.59K derived: sum of 4 quarters · filed 2019-11-14 | ||||
| 2018-06-30 | $43.07K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $40.18K 10-Q · filed 2019-08-14 | $603.77K derived: sum of 3 quarters · filed 2019-08-14 | $580.30K derived: sum of 4 quarters · filed 2019-08-14 | ||||
| 2018-03-31 | -$2.89K 10-Q · filed 2019-05-14 | $560.70K derived: sum of 2 quarters · filed 2019-05-14 | $537.24K derived: sum of 3 quarters · filed 2019-05-14 | $514.24K derived: sum of 4 quarters · filed 2019-05-14 | ||||
| 2017-12-31 | $563.59K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-28 | $540.12K derived: sum of 2 quarters · filed 2019-03-28 | $517.12K derived: sum of 3 quarters · filed 2019-03-28 | $494.31K 10-K · filed 2019-03-28 | ||||
| 2017-09-30 | -$23.47K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | -$46.47K derived: sum of 2 quarters · filed 2018-11-14 | -$69.28K 10-Q · filed 2018-11-14 | -$92.26K derived: sum of 4 quarters · filed 2018-11-14 | ||||
| 2017-06-30 | -$23.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | -$45.82K 10-Q · filed 2018-08-14 | -$68.79K derived: sum of 3 quarters · filed 2018-08-14 | $148.13K derived: sum of 4 quarters · filed 2018-08-14 | ||||
| 2017-03-31 | -$22.82K 10-Q · filed 2018-05-14 | $22.82K 10-Q · filed 2017-05-11 | -$45.79K derived: sum of 2 quarters · filed 2018-05-14 | $171.13K derived: sum of 3 quarters · filed 2018-05-14 | -$261.84K derived: sum of 4 quarters · filed 2018-05-14 | |||
| 2016-12-31 | -$22.97K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $193.94K derived: sum of 2 quarters · filed 2018-04-02 | -$239.02K derived: sum of 3 quarters · filed 2018-04-02 | -$94.76K 10-K · filed 2018-04-02 | $94.76K 10-K · filed 2017-03-31 | |||
| 2016-09-30 | $216.91K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | -$216.05K derived: sum of 2 quarters · filed 2017-11-14 | -$71.79K 10-Q · filed 2017-11-14 | $71.79K 10-Q · filed 2016-11-14 | -$26.60K derived: sum of 4 quarters · filed 2017-11-14 | |||
| 2016-06-30 | -$432.97K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-14 | -$288.70K 10-Q · filed 2017-08-14 | $288.70K 10-Q · filed 2016-08-11 | -$243.51K derived: sum of 3 quarters · filed 2017-08-14 | -$591.71K derived: sum of 4 quarters · filed 2017-08-14 | |||
| 2016-03-31 | $144.26K 10-Q · filed 2017-05-11 | $189.45K derived: sum of 2 quarters · filed 2017-05-11 | -$158.74K derived: sum of 3 quarters · filed 2017-05-11 | $15.53K derived: sum of 4 quarters · filed 2017-05-11 | ||||
| 2015-12-31 | $45.19K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$303.01K derived: sum of 2 quarters · filed 2017-03-31 | -$128.73K derived: sum of 3 quarters · filed 2017-03-31 | $45.19K 10-K · filed 2017-03-31 | ||||
| 2015-09-30 | -$348.20K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-14 | -$173.92K derived: sum of 2 quarters · filed 2016-11-14 | $0.00 10-Q · filed 2016-11-14 | |||||
| 2015-06-30 | $174.28K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-11 | $348.20K 10-Q · filed 2016-08-11 | ||||||
| 2015-03-31 | $173.92K 10-Q · filed 2016-05-16 | |||||||
| 2014-12-31 | -$404.06K 10-K · filed 2016-03-30 | |||||||
| 2014-06-30 | $430.48K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-28 | $0.00 10-Q · filed 2015-12-28 | ||||||
| 2014-03-31 | -$430.48K 10-Q · filed 2015-12-28 | |||||||
| 2013-12-31 | $0.00 10-K · filed 2015-12-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NANOVIRICIDES, INC. (NNVC) | United States | $0.031B | |
| Propanc Biopharma, Inc. (PPCB) | $0.032B | -0.13 | |
| BeyondSpring Inc. (BYSI) | United States | $0.031B | -10.95 |
| Context Therapeutics Inc. (CNTX) | United States | $0.034B | -1.10 |
| IGC Pharma, Inc. (IGC) | United States | $0.029B | -5.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Hepion Pharmaceuticals, Inc. (HEPA) | United States | $0.029B | -0.62 |
| Transcode Therapeutics, Inc. (RNAZ) | United States | $0.029B | -0.12 |
| KYNTRA BIO, INC. (KYNB) | United States | $0.028B | 0.17 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |